Tetra Bio-Pharma Inc.
TBP
Rank in Stocks
#35460
Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical... Headquartered in Orléans, Canada, Tetra Bio-Pharma Inc. is a biopharmaceutical company focused on discovering and developing cannabinoid-based medications. Their efforts span several therapeutic areas, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features various drug candidates: PLENITUDE is being developed for cancer-related pain in advanced patients, while REBORN addresses breakthrough cancer pain. Reduvo is designed to combat chemotherapy-induced nausea and vomiting. ARDS-003 targets sepsis and the prevention of acute respiratory distress syndrome, and SERENITY aims to treat cancer cachexia. Furthermore, Tetra Bio-Pharma is advancing PPP003 for painful dry eye and uveitis pain, and HCC011 for hepatocellular carcinoma.
Share Price
$0.01851783
Last synced: 2023-05-23
Market Cap
$3.71M
Change (1 day)
-0.04%
Change (1 year)
1,443.15%
Country
CA
Trade Tetra Bio-Pharma Inc. (TBP)
Category
Healthcare
EPS for Tetra Bio-Pharma Inc. (TBP)
EPS as of 2026 TTM: 0
According to Tetra Bio-Pharma Inc. latest financial reports and stock price the company's current EPS (TTM) is 0. At the end of 2026 the company had a EPS of 0 equal to its 2026 EPS that were of 0.
EPS history for Tetra Bio-Pharma Inc. from 2026 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| Not enough data for the provided dates. | ||
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $17.32 | - |
US
|
|
| $-7.98 | - |
US
|
|
| $-5.29 | - |
AU
|
|
| - | - |
CH
|
|
| $27.74 | - |
NL
|
